Advertisement

Topics

LA BioMed Company Profile

14:51 EST 13th December 2018 | BioPortfolio

The Los Angeles BioMedical Research Institute conducts biomedical research, provides education and training of scientists, and provides a variety of community services such as nutritional assistance, childhood immunization, anti-violence programs and various disease education initiatives.LA BioMed is located in Los Angeles County on the campus of Harbor-UCLA Medical Center. LA BioMed is a freestanding, not-for-profit biomedical research, training and service organization. It is an affiliate of both the UCLA School of Medicine and the Harbor-UCLA Medical Center, and has an annual budget of $58 million.

Location

1124 W. Carson Street
Torrance
California
90502
United States of America

Contact

Phone: 877-452-2674


News Articles [134 Associated News Articles listed on BioPortfolio]

Q BioMed Acquires Cancer Pain Drug From GE Healthcare

NewsThe acquisition of Metastron gives Q BioMed ownership of the drug and related market authorizations in 22 countries.Contributed Author: 

Q BioMed and SRI Collaborate on Formulation and Preclinical Work on Autism

NewsThe collaborative agreement will include early clinical manufacturing of QBM-001 in support of Q BioMed's Autistic Spectrum Disorder drug development program.

Harbour BioMed gets rights to Glenmark's bispecific antibody

Glenmark Pharmaceuticals SA granted Harbour BioMed exclusive rights to develop and sell its bispecific antibody GBR1302 for solid tumors in Greater China. Harbour BioMed also retains a manufacturing o...

Harbour BioMed raises $85m to accelerate growth of therapeutic pipeline

Harbour BioMed is engaged in the discovery and development of therapeutics for oncology and immunological diseases. The financing round was led by GIC Private Limited, and participants included The p...

Q BioMed takes final step to gaining FDA approval to manufacture its spearhead drug

Q BioMed Inc (OTCQB: QBIO) CEO Denis Corin tells Proactive Investors the commercial-stage biotech is taking the final step in the approval process of its bone pain relief treatment, the "spearhead'"...

Orchestra BioMed secures $41m funding for cardiovascular product candidates

Orchestra BioMed will use the funding to support continued late-stage clinical development of its Virtue sirolimus-eluting balloon (SEB) to treat artery disease and BackBeat cardiac neuromodulation th...

Q BioMed’s Metastron acquisition ‘positive development,’ advances pipeline, says Brookline Capital Markets

Analyst Kumaraguru Raja says Q BioMed’s ownership of this non-opioid cancer pain drug will give it ‘immediate, established, and long-term revenue’

Deals this week: Harbour BioMed, Emergent BioSolutions, Sierra Oncology

Harbour BioMed has signed a collaboration agreement with Kelun-Biotech Biopharmaceutical to develop and commercialise A167, an anti-PD-L1 antibody indicated for...Read More... The post Deals this week...

Drugs and Medications [0 Results]

None

PubMed Articles [22 Associated PubMed Articles listed on BioPortfolio]

Comment on "Using Innovative Acoustic Analysis to Predict the Postoperative Outcomes of Unilateral Vocal Fold Paralysis".

Corrigendum to "Carnitine/organic cation transporter 2 (OCTN2) contributes to rat epididymal epithelial cell growth and proliferation" Biomed. Pharmacother. 93(2017):444-450.

BITS 2017: the annual meeting of the Italian Society of Bioinformatics.

This preface introduces the content of the BioMed Central journal Supplement related to the 14th annual meeting of the Bioinformatics Italian Society, held in Cagliari, Italy, from the 5th to the 7th ...

Quercetin Stimulates Bone Marrow Mesenchymal Stem Cell Differentiation through an Estrogen Receptor-Mediated Pathway.

The present study aimed to investigate the overall effect of quercetin on mouse bone marrow mesenchymal stem cell (BMSC) proliferation and osteogenic differentiation .

Partially systematic thoughts on the history of systematic reviews.

Six years after the launch of Systematic Reviews by Biomed Central, this article is part of the celebration of the journal. It contains personal reflections on the past, present and future of systemat...

Clinical Trials [7 Associated Clinical Trials listed on BioPortfolio]

Amendment of rTSST-1 Variant Vaccine Phase 1 First-in-man Trail

Toxic Shock Syndrome (TSS) a severe condition with high morbidity and mortality results from the hosts overwhelming inflammatory response and cytokine storm. Staphylococcal superantigen to...

Reproducibility of Malaria Challenge in Healthy Volunteers

This is a prospective, single arm, single intervention safety and immunogenicity study in 6 healthy, malaria-naive adults, conducted to demonstrate the successful implementation of the wel...

WarmSmart Warming Protocol

Hypothermia during surgery and in the postoperative period is associated with adverse outcomes including impaired drug metabolism, cardiac morbidity, shivering, impaired immune function, c...

Treatment and Survival Continuation Study of Atamestane Plus Toremifene vs Letrozole in Advanced Breast Cancer

Protocol 777-CLP-32 is the treatment and survival continuation protocol of Biomed 777-CLP-29, and will continue to compare combined hormonal therapy using the experimental aromatase inhibi...

Color Stability of NeoMTA Pulpotomized Primary Teeth

This randomized control study will use 15 pediatric subjects selected from the patient population in the pediatric dental clinic at Children's Medical Center Dental Clinic (CMC Dental Clin...

Companies [47 Associated Companies listed on BioPortfolio]

Biomed Pharmaceuticals

The Company is a leading pharmacy provider of intravenous and injectable medications for patients with chronic disorders. Biomed treats a variety of immune deficient and autoimmun...

BioMed Central Ltd

BioMed Central is an independent publishing house committed to providing immediate open access to peer-reviewed biomedical researchAll original research articles published by BioMed Central are made f...

Biomed

Biomed AG wurde 1951 in Zürich gegründet und hat sich seither als Handelsunternehmen für pharmazeutische Produkte im Schweizer Markt etabliert. Biomed ist spezialisiert auf den Handel mit rezeptpfl...

Alpine Biomed Corporation

Alpine Biomed is a global leader in specialty diagnostic devices for the gastroenterology and neurology clinical markets. The company produces diagnostic tools used for gastroesophageal reflux diseas...

BioMed Capital Group Ltd.

BioMed principals and affiliates understand the strategic factors that drive future performance, including: Competition and competitive advantages Technology as related to markets served Capital requ...

More Information about "LA BioMed" on BioPortfolio

We have published hundreds of LA BioMed news stories on BioPortfolio along with dozens of LA BioMed Clinical Trials and PubMed Articles about LA BioMed for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of LA BioMed Companies in our database. You can also find out about relevant LA BioMed Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Pediatrics
Pediatrics is the general medicine of childhood. Because of the developmental processes (psychological and physical) of childhood, the involvement of parents, and the social management of conditions at home and at school, pediatrics is a specialty. With ...

Infectious-diseases
Antiretroviral Therapy Clostridium Difficile Ebola HIV & AIDS Infectious Diseases Influenza Malaria Measles Sepsis Swine Flu Tropical Medicine Tuberculosis Infectious diseases are caused by pathogenic...


Corporate Database Quicklinks



Searches Linking to this Company Record